Bacteria Cont, Cell-Wall Antimicrobials (Week 3) Flashcards
(81 cards)
Streptococcus pneumoniae
Pneumococcus
Gram +, encapsulated, lancet shaped, diplococci, facultative anaerobe, alpha-hemolytic, naturally competent
Most common cause of community-acquired pneumonia, bacterial meningitis and meningitis in adults
What allows us to defend against encapsulated bacteria?
ANTIBODIES!
Complement cannot opsonize/phagocytize/membrane attack complex encapsulated bacteria
Pneumococcal pneumonia
From Streptococcus pneumoniae
Purulent exudate-filled alveoli –> bronchopneumonia, lobar pneumonia, cough
Immunity by antibodies because it is encapsulated (infection or vaccine)
Neisseria meningitidis
Gram -, diplococci, encapsulated
Nasopharyngeal carriage and transmitted in respiratory droplets
Virulence factors: LOS endotoxin, secretes IgA1 protease, pili, capsule
Can do transcytosis (bind apical side of cell, transit through cell and exit basolateral side of cell)
Diseases: meningitis (CNS diesase), meningococcemia (septicemia), both together
Drug classes that inhibit cell wall synthesis
Beta-lactam antibiotics: penicillins, cephalosporins; contain 4-membered beta-lactam ring structure
Vancomycin
Bacitracin
Bactericidal; only work on actively proliferating microorganisms
Beta lactam antibiotics
Inhibit transpeptidase enzmes that cross-link peptidoglycan matrix
Ex: Penicillins, cephalosporins
Contain 4-membered beta-lactam ring structure
Bactericidal
Effective against mixture of gram + and gram - bacteria
If bacteria contains beta-lactamase (ie penicillinase or cephalosporinase) then will be resistant to beta-lactam drugs
Penicillins
Interfere with one of final steps in bacterial cell wall synthesis and cause cell lysis
Can cause hypersensitivity
Transpeptidase
Bacterial enzyme that cross-links peptidoglycan matrix to form cell wall
Located in cytoplasmic membrane
AKA penicillin binding proteins (PBPs)
Bordetella pertussis
Gram - coccobacillus (small)
Obligate aerobe
NOT part of normal flora, but live in healthy ciliated epithelial cells in infected people
Disease: Pertussis (whooping cough)
Transmission: respiratory droplets, highly communicable
Clinical features of pertussis (whooping cough)
Incubation period: 7-14 days
Catarrhal phase: 7 days; mild cold-like symptoms
Paroxysmal phase: 1-4 weeks or longer; severe forceful spasmodic coughing followed by inspiratory gasp (whoop), lymphocytosis
Convalescent phase: several weeks; paroxysms less frequent/severe, gradual recovery
In vaccinated populations, where is the reservoir of B. pertussis?
In adolescents and adults, who may be asymptomatic but can give B. pertussis to infants
Note: most cases occur in infants before the vaccine has given immunity
Toxins secreted by B pertussis
1) Adenylate cyclase toxin: binds receptors on neutrophils, CDs, monocytes, is internalized, is activated by calmodulin to turn ATP to cAMP which inhibit the phagocytic cell form phagocytizing (disrupt chemotaxis, phagocytosis, killing bacteria)
2) Pertussis toxin (Ptx): A/B toxin takes ADP portion of NAD and links it to G alpha protein to inhibit its activity, but this G protein is itself inhibitory to adenylate cyclase in the host cell so this causes increase in cAMP in the host cell
3) Tracheal cytotoxin: is a fragment of bacterial peptidoglycan cell wall that stops cilia from beating and kills ciliated cells (this same toxin used by gonococcus)
Haemophilus influenzae
Gram - coccobacillus (small)
Requires hemin (X factor) and NAD (V factor)
Grown on chocolate agar
Strains a-f are encapsulated and nontypeable are nonencapsulated
Diseases: otitis media in kids, pneumonia, epiglottitis, meningitis
Which pathogens have conjugate vaccines?
Streptococcus pneumoniae
Neiserria meningitis
H. influenza
Note: all encapsulated (duh)
Trimethoprim sulfonamide (TMP/SMX)
Widely active against Gram +/-
Used to be used for UTIs but no longer because E coli are more resistant
Tx CA-MRSA, Pneumocystis jiroveci pneumonia
NOT to tx Group A streap or enterococci (intrinsically resistant)
AKA Bactrim
Important properties of sulfonamides
Highly protein bound
Undergo hepatic metabolism
Metabolite excreted by urine (may form crystals or stones in urinary tract)
Many possible toxicities (SJS)
Drug interaction of sulfonamide and phenytoin
Sulfonamide produces phenytoin toxicity (too much phenytoin) because sulfa binds albumin and displaces phenytoin from albumin
How do bacteria become resistant to sulfonamides?
1) Overproduce PABA (increase concentration of substrate so even though sulfa there to inhibit, reaction still proceeds)
2) Mutations in DHFR so that trimethoprim can’t bind/inhibit it
Trimethoprim
Toxicities: nausea and vomiting, hematopoetic problems, interferes with Na/K exchange in kidney (hyperkalemia)
Combination sulfa drugs
Pyrimethamine-sulfadoxine (Fansidar) used to treat malaria
Pyrimethamine-sulfadiazine used to treat toxoplasmosis
Note: sulfa drugs almost never prescribed alone
Use of sulfonamides for other things
Use 1% silver sulfadiazine cream for prophylaxis against infection
Use sodium sulfacetamide drops for conjunctivitis
Where do beta-lactams act?
Act on cell wall
If acting on gram - then must get through porins in outer membrane to act in periplasmic space
Note: mycobacteria have complex cell wall (or NO cell wall??) and beta-lactams usually don’t work against them
Three groups of cell wall synthesis inhibitors
Beta-lactams
Glycopetides
Inhibitor of peptidoglycan precursor transport (Bacitracin, only used topically)
Resistance to beta-lactams and our response
Degradation by beta-lactamases (all S. aureus is resistant because of this), but we combat this by using beta-lactamase inhibitors
Decreased permeability through porins (outer membrane of Gram -), but we combat this by adding different “R” groups to make drugs better able to penetrate (add amino group)
Altered penicillin binding proteins/transpeptidases (MRSA), but all we can do to combat this is to use another type of drug :(